Quinax

Quinax: an effective medicine for the treatment of cataracts

Quinax (azapentacene) is a drug manufactured by Alcon Pharma (USA), Alcon Pharma (Belgium) and Alcon-Couvreur (Belgium). Quinax belongs to the group of metabolic stimulants of different chemical groups. Quinax is presented in the form of eye drops containing 0.15 mg/ml of the active substance - azapentacene.

Quinax has been successfully used to treat cataracts, which can be senile, congenital, traumatic or secondary. Cataract is an eye disease characterized by clouding of the lens, resulting in poor vision. The main active component of Quinax is azapentacene, which blocks oxidative processes and stimulates metabolism in the tissues of the eye, which helps improve vision.

Quinax is not recommended for use in patients with hypersensitivity to azapentacene. When using Quinax, allergic reactions such as burning and itching in the eyelid area may occur. Before starting to use Quinax, you should consult with a specialist to evaluate the indications and contraindications for use.

According to the literature (Encyclopedia of Drugs 2004), the interaction of Quinax with other drugs is not known. There is also no information about the specifics of use and overdose of Quinax.

In conclusion, Quinax is an effective drug for the treatment of cataracts. However, like any other drug, it must be used only as prescribed by a doctor and in accordance with the instructions for use.